MoneyWorks4Me

Medicamen Biotech - Quaterly Results

25 May 2022 Evaluate
The revenue for the March 2022 quarter is pegged at Rs. 227.54 millions, about 11.88% up against Rs. 203.37 millions recorded during the year-ago period.A big decline of -33.57% was reported for the quarter ended March 2022 to Rs. 27.53  millions from Rs. 41.44 millions of corresponding previous quarter.A decline of 53.15 millions was observed in the OP in the quarter ended March 2022 from 54.19 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 227.54 203.37 11.88 1154.45 1101.46 4.81 1154.45 1101.46 4.81
Other Income 3.38 5.37 -37.06 17.20 7.54 128.12 17.20 7.54 128.12
PBIDT 53.15 54.19 -1.92 252.74 203.35 24.29 252.74 203.35 24.29
Interest 5.64 3.60 56.67 14.01 10.64 31.67 14.01 10.64 31.67
PBDT 47.51 50.59 -6.09 238.73 192.71 23.88 238.73 192.71 23.88
Depreciation 15.24 4.15 267.23 57.71 25.20 129.01 57.71 25.20 129.01
PBT 32.27 46.44 -30.51 181.02 167.51 8.07 181.02 167.51 8.07
TAX 4.74 5.00 -5.20 31.97 42.65 -25.04 31.97 42.65 -25.04
Deferred Tax -0.61 0.50 -222.00 -7.80 1.19 -755.46 -7.80 1.19 -755.46
PAT 27.53 41.44 -33.57 149.05 124.86 19.37 149.05 124.86 19.37
Equity 122.17 122.17 0.00 122.17 122.17 0.00 122.17 122.17 0.00
PBIDTM(%) 23.36 26.65 -12.34 21.89 18.46 18.58 21.89 18.46 18.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..